Y. H. Seo, K. S. Carroll / Bioorg. Med. Chem. Lett. 19 (2009) 356–359
357
has an azide chemical handle, which can be functionalized with a
wide variety of phosphine or alkyne-based reporter tags for
detection and isolation.8 In this report, we describe an improved
synthesis of DAz-1 and investigate sulfenic acid formation in the
cell-cycle regulatory phosphatase Cdc25A. In addition, we compare
the activity of DAz-1 to a biotinylated derivative in vitro and in
HeLa cells.
transition and Cdc25B/Cdc25C involved in the G2/M.12 Like all tyro-
sine phosphatases, members of the Cdc family contain an active-
site cysteine involved in formation of a phosphocysteine interme-
diate. The pKa of this active-site residue is significantly perturbed
from the typical 8.5 to ꢀ6.13 Cdc25 phosphatases also possess a
second conserved cysteine located ꢀ5 Å from the active-site resi-
due. This additional cysteine is not required for activity, but can
form an intramolecular disulfide with the catalytic cysteine under
mild oxidizing conditions.14 The proposed function of this disulfide
is to prevent overoxidation of the catalytic cysteine to irreversible
sulfinic and sulfonic acid forms.
Biochemical studies indicate that the active-site cysteine in
Cdc25B and Cdc25C is sensitive to oxidants and that sulfenic acid
formation inhibits phosphatase activity.15 However, it is not
known whether Cdc25A—the only essential Cdc25 isoform—is sus-
ceptible to oxidation. Therefore, we treated the recombinant solu-
ble catalytic domain of Cdc25A C384S16 with DAz-1 and
conjugated it to biotin reporter tags 9 or 10 using the Staudinger
ligation or click chemistry, respectively (Scheme 2). Western blot
analysis shows DAz-1-dependent labeling of Cdc25A C384S
(Fig. 2). Pre-treatment of the phosphatase with the reducing agent
dithiothreitol (DTT) significantly reduced labeling, as expected
(Fig. S1a). Trapping the sulfenic acid modification also blocked for-
mation of disulfide-linked Cdc25A homodimers (Fig. S1b). Taken
together, these data indicate that the active-site cysteine in Cdc25A
can oxidize to a sulfenic acid, which can be trapped by DAz-1. Since
Cdc25A expression is elevated in a wide variety of cancers,12 small-
molecules inhibitors, which target the phosphatase active-site and
are sensitive to the redox state of the catalytic cysteine, may inhibit
proliferation of transformed cells that are associated with high lev-
els of ROS.
In recent work, Charles and colleagues reported a biotinylated
dimedone derivative to monitor protein sulfenic acid formation
in peroxide-treated rat ventricular myocytes.17 In their studies,
Charles et al. observed protein labeling only when primary cells
were treated with hydrogen peroxide.17 One interpretation of
these data is that the basal level of cellular sulfenic acids in pri-
mary myocytes is below the threshold of detection. Alternatively,
since oxidants stimulate programed cell death and necrosis in cul-
tured cells,18,19 it is possible that treatment compromised mem-
brane integrity and allowed the dimedone-biotin derivative to
enter the dying cell. Consistent with the latter proposal, several re-
cent reports demonstrate that direct conjugation of a reporter tag
such as biotin or a fluorophore to an inhibitor reduces potency
and prevents passive diffusion across cell membranes.20,21 For
In a previous report, we pursued the synthesis of DAz-1 via
route A (Scheme 1, a ? b ? c ? f).7 Ni-catalyzed hydrogenation
of 3,5-dihydroxybenzoic acid (7) gave diketone 6 in 85% yield.9 Ini-
tial attempts to couple the carboxylic acid functional group on 6
with 3-azidopropylamine (8)10 using standard peptide coupling re-
agents such as PyBop/TEA, DIC/4-DMAP or TBTU/DIEA were not
successful and produced nucleophilic substitution products at the
carbonyl carbon of compound 6. To prevent these undesired reac-
tions we protected the ketone 6 as the methyl ether. PTSA cata-
lyzed protection was achieved in MeOH at room temperature to
give compound 5 in 97% yield. The amide coupling reaction of car-
boxylic acid 5 with amine 8 was carried out with TBTU and DIEA in
DMF to provide amide 3 in 99% yield. The synthesis of DAz-1 was
completed through deprotection of methyl vinyl ether with 2 N
HCl in THF. The overall yield of DAz-1 through route A was 64%.
In small-scale reactions amide coupling with TBTU, an HOBt-
based aminium salt, afforded DAz-1 in excellent yield. However,
when the reaction was scaled up compound DAz-1 and HOBt were
not completely resolved by silica gel chromatography. Although re-
verse phase HPLC could be used to purify DAz-1 the procedure is
time consuming and reduced the overall yield to 20%. For this rea-
son, we explored an alternate synthetic route B (Scheme 1,
a ? b ? d ? e ? f). Pentafluorophenyl trifluoroacetate (TFAPfp)
can activate carboxylic acids as Pfp esters in good yields and vola-
tile side-products TFA and pentafluorophenol are easily removed
during workup.11 Therefore, we used TFAPfp as the activating re-
agent for the carboxylic acid functional group on 5. Esterification
of carboxylic acid 5 was achieved with TFAPfp and DIEA in DMF
in quantitative yield. Pfp ester 4 was then coupled with 3-azido-
propylamine (8) to furnish compound 3 in high purity. For the final
step of the synthesis, we used cerium (IV) ammonium nitrate
(CAN) to deprotect 3. Non-acidic deprotection using catalytic
amount of CAN provided DAz-1 in 96%. Route B did not require
HPLC purification and furnished DAz-1 over five steps in 52% yield.
Having established an efficient synthesis for DAz-1, we next
investigated sulfenic acid formation in the cell-cycle regulatory
phosphatase Cdc25A (Scheme 2). In humans, three different
Cdc25 family members exist with Cdc25A required for the G1/S
Scheme 1. Synthesis of DAz-1 (1). Reagents and conditions: (a) T1 Raney nickel, NaOH, 750 psi, 70 °C, 85%; (b) PTSA, MeOH, rt, 10 min, 97%; (c) 3-azidopropylamine (8), TBTU,
DIEA, DMF, rt, 15 min, 99%; (d) TFAPfp, TEA, DMF, rt, 2 h, 100%; (e) 3-azidopropylamine (8), DIEA, DMF, rt, 3 min, 89%; (f) 2 N HCl, THF, rt, 1 h, 78% or CAN, H2O-MeCN, reflux,
1 h, 96%.